NLM logo

NCI_CTCAE_3 (Common Terminology Criteria for Adverse Events 3.0) - Synopsis


This source is no longer available in the current version of the UMLS Metathesaurus. To obtain content from this source, download the 2022AA UMLS release. The content is also available in the UMLS History Files.


Web site:
http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm

Authority
The U.S. National Cancer Institute (NCI) produces the Common Terminology Criteria for Adverse Events (CTCAE).

Purpose
CTCAE aids the reporting of adverse events that occur to patients enrolled in cancer therapy clinical trials.

Description
CTCAE is a standard classification and severity grading scale for adverse events in clinical trials and oncology settings.

CTCAE corresponds with MedDRA at its Adverse Event level. Information systems can integrate CTCAE to exchange safety data and to enable data management for collecting and analyzing adverse event data.

For other versions of CTCAE, see:

  1. Common Terminology Criteria for Adverse Events 4.3 Subset
  2. Common Terminology Criteria for Adverse Events 5.0

Metathesaurus Update Frequency
CTCAE is included annually as part of the NCI Thesaurus in the Metathesaurus.

Sites Consulted

  1. Common Terminology Criteria for Adverse Events (CTCAE)